
Semaglutide
GLP-1 weekly injection — the proven foundation
Once-weekly GLP-1 receptor agonist that reduces hunger signals, slows gastric emptying, and improves blood sugar control. The most studied GLP-1 protocol — patients typically see steady, sustained weight changes.
3-month starter program
Best for: Most patients with BMI 27+ or weight-related health conditions
- What it is
- A compounded GLP-1 receptor agonist delivered as a once-weekly subcutaneous injection. Acts on the appetite and gastric-emptying pathways to support a calorie deficit.
- Timeline
- Most patients notice appetite changes within the first 1–2 weeks. Dose is titrated up over the first 12 weeks to find the lowest effective level for you.
- Monitoring
- Initial labs reviewed by your provider, monthly check-ins, and quarterly bloodwork. Dose is adjusted based on tolerance, labs, and how you feel.












